Literature DB >> 2070778

Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker.

L J Deftos1.   

Abstract

CgA is a 49 kilodalton protein that is present in the secretory granules of most endocrine and many neuroendocrine cells. Detection of CgA in cells by immunocytochemistry and measurement of CgA in serum by immunoassay can serve as tissue and serum markers for CgA-producing tumors. CgA is of diagnostic value in classical endocrine tumors, in hormone-negative tumors, and in endocrine tumors in which other diagnostic procedures have their limitations. Although the biological function of CgA is yet unknown, it may serve as a precursor molecule, like POMC, for a family of biologically active peptides. CgA is an important new tool for the endocrinologist in the diagnosis and management of patients with endocrine and neuroendocrine tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070778     DOI: 10.1210/edrv-12-2-181

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  64 in total

Review 1.  Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.

Authors:  Aaron H Mendelson; Mark Donowitz
Journal:  Dig Dis Sci       Date:  2017-08-03       Impact factor: 3.199

2.  Selective gene expression by rat gastric corpus epithelium.

Authors:  M Goebel; A Stengel; N W G Lambrecht; G Sachs
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

3.  Development of a microplate assay for serum chromogranin A (CgA): establishment of normal reference values and detection of elevated CgA in malignant diseases.

Authors:  T L Wu; C P Chang; K C Tsao; C F Sun; J T Wu
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Different patterns of serum chromogranin A in patients with prostate cancer with and without undergoing hormonal therapy.

Authors:  J T Wu; T L Wu; C P Chang; K C Tsao; C F Sun
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

5.  Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.

Authors:  Mark Kidd; Irvin M Modlin; Shrikant M Mane; Robert L Camp; Michael D Shapiro
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

6.  Characterization of serum and urinary chromogranin A by size exclusion chromatography: impact on calibrator selection and urinary assay.

Authors:  K C Tsao; G H Liu; P Y Chang; C N Lin; T L Wu; C F Sun; J T Wu
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 7.  Melanotrope cells as a model to understand the (patho)physiological regulation of hormone secretion.

Authors:  R Vàzquez-Martínez; J R Peinado; D Cruz-García; A Ruiz-Navarro; F Gracia-Navarro; Y Anouar; M C Tonon; H Vaudry; J P Castaño; M M Malagón
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

Review 8.  The biology and clinical implications of prostate cancer dormancy and metastasis.

Authors:  Colm Morrissey; Robert L Vessella; Paul H Lange; Hung-Ming Lam
Journal:  J Mol Med (Berl)       Date:  2015-10-21       Impact factor: 4.599

9.  High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis.

Authors:  Magdy El-Salhy; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

10.  In vivo imaging of chromogranin A-positive endocrine tumours by three-step monoclonal antibody targeting.

Authors:  A G Siccardi; G Paganelli; A E Pontiroli; M Pelagi; P Magnani; G Viale; G Faglia; F Fazio
Journal:  Eur J Nucl Med       Date:  1996-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.